share_log

Piper Sandler Maintains Overweight on Cresco Labs, Lowers Price Target to $6

Piper Sandler Maintains Overweight on Cresco Labs, Lowers Price Target to $6

派珀·桑德勒維持對Cresco Labs的增持,將目標股價下調至6美元
Benzinga Real-time News ·  2022/08/18 07:58

Piper Sandler analyst Michael Lavery maintains Cresco Labs (OTC:CRLBF) with a Overweight and lowers the price target from $9 to $6.

派珀·桑德勒分析師邁克爾·拉弗裏維持Cresco Labs(場外交易代碼:CRLBF)增持,並將目標股價從9美元下調至6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論